Skip to main content
SpringerLink
Log in

Altropane®

O 587

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Three presentations outline success of altropane for rapid diagnosis of Parkinson’s disease. Business Wire [online]. [2 pages], 5 Jun 1997. Available from: URL: http://biz.yahoo.com

    Google Scholar 

  2. Boston Life Sciences announces interim results for its phase II trial of Parkinson’s disease diagnostic agent altropane. Business Wire [online]. [2 pages], 27 Jan 1999. Available from: URL: http://www.newspage.co

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altropane®. Drugs R&D 3, 188–189 (2002). https://doi.org/10.2165/00126839-200203030-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203030-00009

Keywords

Search

Navigation